with us
together we’re making a difference

News Releases

Nov 09, 2021 |

Annexon Biosciences Announces Business and Program Highlights and Reports Third Quarter 2021 Financial Results

Oct 04, 2021 |

Annexon Biosciences Further Strengthens Its Executive Leadership Team With Appointment of Ted Yednock, Ph.D., to Chief Innovation Officer and Appointment of Larry Mattheakis, Ph.D., as Chief Scientific Officer

Sep 23, 2021 |

Annexon Biosciences to Participate in 2021 Cantor Virtual Global Healthcare Conference

Sep 20, 2021 |

Annexon Biosciences to Highlight Neurodegeneration Franchise in Upcoming Virtual C1q Series R&D Event

Aug 16, 2021 |

Annexon Biosciences Reports Second Quarter 2021 Financial Results and Provides Mid-Year Business Update

Jul 22, 2021 |

Annexon Broadens Autoimmune Franchise with Advancement of Third Anti-C1q Product Candidate and Strategic Expansion into New Autoantibody-driven Diseases

Jun 16, 2021 |

Annexon to Present at the Raymond James Human Health Innovation Conference

May 17, 2021 |

Annexon Biosciences Provides Business Update and Reports First Quarter 2021 Financial Results

May 05, 2021 |

Annexon to Present at the BofA Securities 2021 Virtual Healthcare Conference

Mar 25, 2021 |

Annexon Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results with Recent Business Highlights
Displaying 1 - 10 of 14
Print
IR Contact
RSS Feeds
Email Alerts
Contact Us

info@annexonbio.com
650.822.5500

Annexon Biosciences

1400 Sierra Point Parkway,
Building C, 2nd Floor
Brisbane, CA 94005

© 2021 Annexon Inc. All rights reserved.